Metoprolol Orion 47.5 mg depottabletti Finlandia - fiński - Fimea (Suomen lääkevirasto)

metoprolol orion 47.5 mg depottabletti

orion corporation - metoprolol succinate - depottabletti - 47.5 mg - metoprololi

Metoprolol Orion 95 mg depottabletti Finlandia - fiński - Fimea (Suomen lääkevirasto)

metoprolol orion 95 mg depottabletti

orion corporation - metoprolol succinate - depottabletti - 95 mg - metoprololi

Metoprolol Orion 190 mg depottabletti Finlandia - fiński - Fimea (Suomen lääkevirasto)

metoprolol orion 190 mg depottabletti

orion corporation - metoprolol succinate - depottabletti - 190 mg - metoprololi

Focetria Unia Europejska - fiński - EMA (European Medicines Agency)

focetria

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - influenssarokot - a (h1n1v) 2009 -viruksen aiheuttaman influenssan profylaksia. focetria-rokotetta tulee käyttää virallisen ohjeistuksen mukaisesti.

Foclivia Unia Europejska - fiński - EMA (European Medicines Agency)

foclivia

seqirus s.r.l.  - influenssaviruksen pinta-antigeenit, inaktivoitu: a / vietnami / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenssarokot - influenssan ennaltaehkäisy virallisesti ilmoitetussa pandemiatilanteessa. pandemian influenssarokote on käytettävä virallisten ohjeiden mukaisesti.

Thyrogen Unia Europejska - fiński - EMA (European Medicines Agency)

thyrogen

sanofi b.v. - tirotropiini alfa - kilpirauhasen vajaatoiminta - anterior aivolisäkkeen etulohkon hormonit ja analogit, aivolisäkkeen ja hypotalamuksen hormonit sekä analogit - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Sunlenca Unia Europejska - fiński - EMA (European Medicines Agency)

sunlenca

gilead sciences ireland unlimited company - lenacapavir sodium - hiv-infektiot - antiviraalit systeemiseen käyttöön - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 ja 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 ja 5.

IODOSORB  puuteri Finlandia - fiński - Fimea (Suomen lääkevirasto)

iodosorb puuteri

perstorp ab, division perstorp pharma - cadexomerum jodia - puuteri - muut haavojen ja palovammojen hoitoon tarkoitetut valmisteet

IODOSORB 0.9 % puuteri Finlandia - fiński - Fimea (Suomen lääkevirasto)

iodosorb 0.9 % puuteri

smith & nephew oy - cadexomerum jodia - puuteri - 0.9 % - kadeksomeerijodi

IODOSORB 0.9 % voide Finlandia - fiński - Fimea (Suomen lääkevirasto)

iodosorb 0.9 % voide

smith & nephew oy - cadexomerum jodia - voide - 0.9 % - kadeksomeerijodi